口蹄疫疫苗市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Foot and Mouth Disease Vaccines Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月26日 | 出版商:

Global Market Insights Inc. | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球口蹄疫 (FMD) 疫苗市場價值為 25 億美元，預測顯示出成長軌跡，預計 2024 年至 2032 年複合年成長率為 7.7%。政府實體採取積極措施以及畜產品商業化蓬勃發展。

口蹄疫 (FMD) 是一種病毒感染，具有高度傳染性，影響豬、牛、山羊和綿羊等動物。此病毒屬於小核糖核酸病毒科，會出現發燒、口腔、腳部、偶爾在乳頭上出現水泡等症狀。口蹄疫在全球的廣泛流行是市場擴張的關鍵驅動力。例如，世界動物衛生組織 2023 年的資料強調，口蹄疫病毒存在於全球約 77% 的牲畜族群中，特別是在非洲、中東、亞洲和南美洲等地區。

有鑑於口蹄疫對牲畜健康、農業生產力和經濟穩定的深遠影響，全球各國政府正在加強口蹄疫疫苗接種力度。這些努力旨在提高疫苗的可及性，確保廣泛的免疫接種，並促進口蹄疫控制和根除方面的國際合作。例如，2022年8月，昆士蘭州政府撥款2,000萬美元加強其FMD防禦戰略。

整個產業分為疫苗類型、動物類型、配銷通路和地區。

市場將疫苗分為常規疫苗和緊急疫苗。傳統疫苗又進一步分為氫氧化鋁疫苗、皂苷疫苗和油疫苗。 2023年，傳統疫苗以83.9%的佔有率佔據市場主導地位。幾個關鍵因素推動了對傳統口蹄疫疫苗的需求。影響偶蹄動物的口蹄疫可能會對畜牧業造成嚴重的經濟影響，包括生產力下降、貿易限制和廣泛的控制措施。

口蹄疫疫苗依動物種類分為牛、綿羊和山羊、豬等。 2023 年，牛類市場的估值為14 億美元，引領市場。嚴重症狀。

2023 年，北美 FMD 疫苗市值為 7.034 億美元，預計到 2032 年複合年成長率為 6.7%。由於口蹄疫疫情對牲畜和農業經濟帶來嚴重風險，人們更加關注預防策略。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Biogenesis Bago
Biovet Private Ltd
Brilliant Bio Pharma Private Limited
BVI
C.H. Boehringer Sohn AG and Co. KG
Ceva Sante Animale
Indian Immunologicals Ltd.
Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
Kenya Veterinary Vaccines Production Institute
Merck and Co., Inc.
MEVAC

簡介目錄

Product Code: 11014

The Global Foot and Mouth Disease (FMD) vaccines market was valued at USD 2.5 billion in 2023, with projections indicating a growth trajectory, with an anticipated CAGR of 7.7% from 2024 to 2032. This growth is largely fueled by the increasing frequency of FMD outbreaks, proactive measures by government entities, and a booming livestock product commercialization.

Foot and mouth disease (FMD) is a viral infection, highly contagious, impacting animals like pigs, cattle, goats, and sheep. The virus, part of the Picornaviridae family, presents symptoms, such as fever and blisters in the mouth, on the feet, and occasionally on the teats. The widespread prevalence of FMD globally is a key driver for the market expansion. For example, data from the World Organization for Animal Health in 2023 highlighted that the FMD virus is present in about 77% of the global livestock population, notably in regions like Africa, the Middle East, Asia, and South America.

Recognizing the profound effects of FMD on livestock health, agricultural productivity, and economic stability, governments globally are ramping up their FMD vaccination initiatives. These efforts aim to enhance vaccine accessibility, ensure widespread immunization, and promote international collaboration for FMD control and eradication. For instance, in August 2022, Queensland's government allocated USD 20 million to strengthen its FMD defense strategies.

The overall industry is segmented into vaccine type, animal type, distribution channel, and region.

The market segments vaccines into conventional and emergency types. Within conventional vaccines, there is a further division into aluminium hydroxide and saponin-based and oil-based. In 2023, conventional vaccines dominated the market with an 83.9% share. Several pivotal factors drive the demand for conventional FMD vaccines. FMD, affecting cloven-hoofed animals, can lead to severe economic repercussions in the livestock sector, including reduced productivity, trade limitations, and extensive control measures.

Vaccines for FMD are categorized based on the animal type into cattle, sheep and goats, pigs, and others. The cattle segment led the market with a valuation of USD 1.4 billion in 2023. Being primary hosts for the virus, cattle show heightened susceptibility to FMD, often manifesting severe symptoms like fever, lameness, and characteristic vesicles on their feet, mouth, and teats.

North America FMD vaccines market was valued at USD 703.4 million in 2023, with projections indicating a 6.7% CAGR through 2032. The rising adoption of FMD vaccines underscores a commitment to protecting livestock and the broader agricultural sector from this viral threat. With FMD outbreaks posing severe risks to livestock and the agricultural economy, there is an intensified focus on preventive strategies.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising research and development activities for animal healthcare
  - 3.2.1.2 Frequent FMD outbreaks
  - 3.2.1.3 Government initiatives and regulations
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 New emerging therapies
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Vaccine Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Conventional vaccines
- 5.2.1 Aluminium hydroxide and saponin-based vaccines
- 5.2.2 Oil-based vaccines
5.3 Emergency vaccines

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Cattle
6.3 Sheep and Goat
6.4 Pig
6.5 Other animals

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Veterinary hospitals and clinics
7.3 Government institutions
7.4 Retail pharmacies
7.5 Online pharmacies

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa